Clinical Trial Update: Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization has completed, providing updated comparative data on sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)
• TAXUS Paclitaxel-Eluting Stent (paclitaxel-eluting stent)

Snippet

Sponsor: University of Bern | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED